High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo
Journal of Controlled Release · 2023-05 · 357 · 394-403
DOI: 10.1016/j.jconrel.2023.04.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-05. Verfasst von Sebastian G Huayamares und 18 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA. Hauptthemen laut MEDLINE: Nanoparticles, Head and Neck Neoplasms. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) are a clinically relevant way to deliver therapeutic mRNA to hepatocytes in patients. However, LNP-mRNA delivery to end-stage solid tumors such as head and neck squamous cell carcinoma (HNSCC) remains more challenging. While scientists have used in vitro assays to evaluate potential nanoparticles for HNSCC delivery, high-throughput delivery assays performed directly in vivo have not been reported. Here we use a high-throughput LNP assay to evaluate how 94 chemically distinct nanoparticles delivered nucleic acids to HNSCC solid tumors in vivo. DNA barcodes were used to identify LNPHNSCC, a novel LNP for systemic delivery to HNSCC solid tumors. Importantly, LNPHNSCC retains tropism to HNSCC solid tumors while minimizing off-target delivery to the liver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
- Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
- Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA 30332, USA; Department of Chemical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
- Department of Pediatrics, Emory University, Atlanta, GA 30322, USA.
- Department of Pediatrics, Emory University, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA. Electronic address: esorscher@emory.edu.
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA. Electronic address: james.dahlman@bme.gatech.edu.
Förderung
- NIDCR NIH HHS
- National Institutes of Health
Zitieren
APA
Huayamares, S. G., Lokugamage, M. P., Rab, R., Da Silva Sanchez, A. J., Kim, H., Radmand, A., Loughrey, D., Lian, L., Hou, Y., Achyut, B. R., Ehrhardt, A., Hong, J. S., Sago, C. D., Paunovska, K., Echeverri, E. S., Vanover, D., Santangelo, P. J., Sorscher, E. J., & Dahlman, J. E. (2023). High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo. Journal of Controlled Release, 357, 394-403. https://doi.org/10.1016/j.jconrel.2023.04.005
Vancouver
Huayamares SG, Lokugamage MP, Rab R, Da Silva Sanchez AJ, Kim H, Radmand A, et al. High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo. Journal of Controlled Release. 2023;357:394-403. doi:10.1016/j.jconrel.2023.04.005
BibTeX
@article{Huayamares2023,
author = {Huayamares, Sebastian G and Lokugamage, Melissa P and Rab, Regina and Da Silva Sanchez, Alejandro J and Kim, Hyejin and Radmand, Afsane and Loughrey, David and Lian, Liming and Hou, Yuning and Achyut, Bhagelu R and Ehrhardt, Annette and Hong, Jeong S and Sago, Cory D and Paunovska, Kalina and Echeverri, Elisa Schrader and Vanover, Daryll and Santangelo, Philip J and Sorscher, Eric J and Dahlman, James E},
title = {High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo},
journal = {Journal of Controlled Release},
year = {2023},
volume = {357},
pages = {394--403},
doi = {10.1016/j.jconrel.2023.04.005}
}
EUVIMED